Announcements Trials
Browse Landscape

Phase

Phase 1 124Phase 1/2 81Phase 2 66Phase 3 26Phase NA 13Phase EARLY_PHASE1 4Phase 4 2Phase 2/3 2

Status

Unknown 1Terminated 1Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 20INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Breast 2Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Multiple Myeloma 19Solid Tumor 18Breast Neoplasms 14Sarcoma 13Head and Neck Neoplasms 13Colorectal Neoplasms 13Neoplasms 12Lymphoma, B-Cell 12Squamous Cell Carcinoma of Head and Neck 11Pancreatic Neoplasms 11Leukemia, Myeloid, Acute 11Stomach Neoplasms 10Melanoma 10Lymphoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Prostatic Neoplasms 7Leukemia 7Burkitt Lymphoma 7Advanced Solid Tumors 7Ovarian Neoplasms 6Hematologic Neoplasms 6Glioblastoma 6Recurrence 5Osteosarcoma 5Lymphoma, Non-Hodgkin 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasm Metastasis 4

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × INDUSTRY × Endometrial Neoplasms × Clear all
NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Radiopharm Theranostics, Ltd

Phase EARLY_PHASE1 Recruiting
30 enrolled
BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07316361 2026-01-07

GYNORYLAQâ„¢

Biogenea Pharmaceuticals Ltd.

Phase EARLY_PHASE1 Enrolling by invitation
40 enrolled
Gynecologic

Endometrial Neoplasms

NCT03514121 2024-11-22

FPA150-001

Five Prime Therapeutics, Inc.

Phase EARLY_PHASE1 Terminated
95 enrolled 36 charts
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05812677 2023-04-14

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

Shanghai Yunying Medical Technology

Phase EARLY_PHASE1 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡